Clinical Trial: Uterine Cavity and Blood Flow After Conservative Management of Placenta Previa/Accreta

Study Status: Recruiting
Recruit Status: Recruiting
Study Type: Observational

Official Title: Evaluation of the Uterine Cavity and Blood Flow After Conservative Management of Placenta Previa/Accreta

Brief Summary: Bleeding is the most significant cause of maternal death worldwide with more than half of those occurring within the first day of delivery. About 10.5% (some estimate as high at 12-17%) of live births world-wide, or about 14 million births, are complicated by postpartum hemorrhage; a woman dies every 4 minutes from postpartum hemorrhage. Uterine atony and placenta accreta are the two leading causes of postpartum hysterectomies with up to 64% of Cesarean hysterectomies done for abnormally adherent placentation

Detailed Summary: No previous studies performed for evaluation of the effect of those procedures on the uterine cavity or uterine blood flow. Most of the studies in the literature evaluated the menstrual and fertility outcome after conservative measures for intraoperative hemorrhage due to placenta previa/accreta were retrospective and depend on the resumption of menses and pregnancy rate
Sponsor: Assiut University

Current Primary Outcome: The mean difference in the uterine arteries diameters in both groups [ Time Frame: 3 months ]

Original Primary Outcome: Same as current

Current Secondary Outcome:

Original Secondary Outcome:

Information By: Assiut University

Dates:
Date Received: August 22, 2016
Date Started: January 15, 2017
Date Completion: February 2019
Last Updated: May 18, 2017
Last Verified: May 2017